# Tolerance to NeuroEPO in Parkinson Disease

> **NCT04110678** · PHASE1,PHASE2 · COMPLETED · sponsor: **International Center for Neurological Restoration, Cuba** · enrollment: 26 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** NeuroEPO

## Key facts

- **NCT ID:** NCT04110678
- **Lead sponsor:** International Center for Neurological Restoration, Cuba
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-01
- **Primary completion:** 2016-02-11
- **Final completion:** 2017-01-01
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2020-07-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04110678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04110678, "Tolerance to NeuroEPO in Parkinson Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04110678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*